Impacts of in vivo and in vitro exposures to tamoxifen: comparative effects on human cells and marine organisms
Tamoxifen (TAM) is a first generation-SERM administered for hormone receptor-positive (HER+) breast cancer in both pre- and post-menopausal patients and may undergo metabolic activation in organisms that share similar receptors and thus face comparable mechanisms of response. The present study aimed...
Autor principal: | |
---|---|
Outros Autores: | , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2020
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.1/13685 |
País: | Portugal |
Oai: | oai:sapientia.ualg.pt:10400.1/13685 |